Horio Takamasa

Senior Associate

Takamasa Horio

Print profile

Languages
JapaneseEnglish

Contact Information

TEL
+81-3-6266-8781
FAX
+81-3-6266-8681

Practice Areas

Takamasa Horio:News

Public Service
Takamasa Horio became the member of the Toyama Prefecture GMP Inspection Investigative Committee
Public Service
Takamasa Horio became the Adviser for The Japan Federation of Medical Devices Associations
Public Service
Takamasa Horio became the member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council

View All

Takamasa Horio:Seminars

Nov. 11, 2019External Seminars
"16th DIA Japan Annual Meeting 2019 ""How MA/MSL should be?""
Nov. 11, 2019External Seminars
"16th DIA Japan Annual Meeting 2019 "A Practical Approach to the Guidelines on Pharmaceutical Product Communications""
Nov. 12, 2018External Seminars
"15th DIA Japan Annual Meeting 2018 "Guidelines on Pharmaceutical Product Communications""

View All

Takamasa Horio:Publications

Magazine Article
"Practical Responses Based on the Revised Pharmaceuticals and Medical Devices Act (Enforcement Date: August 1, 2021) (2; Final)"
Magazine Article
"Practical Responses Based on the Revised Pharmaceuticals and Medical Devices Act (Enforcement Date: August 1, 2021) (1)"
Book Article
"Legal Commentary: the Pharmaceuticals and Medical Devices Act"

View All

Takamasa Horio:Other

Background

  • Doshisha University (LL.B., 2006)
  • Kyoto University Law School (J.D., 2008)
  • Northwestern University Pritzker School of Law (LL.M. with honors, 2016)
  • Kellogg School of Management (Certificate in Business Administration, 2016)
  • with Jenner & Block LLP, Chicago (2016-2017)
  • seconded to the Pharmaceutical Safety and Environmental Health Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (as Legal Adviser)(2017-2020)

Major Activities

  • Member of the Exploratory Committee on Promotion of Remanufactured SUD for the Project to Establish Remanufactured SUD Standards, Ministry of Health, Labour and Welfare(2020-)
  • Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development(2020-)
  • Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-)
  • Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021-)
  • Adviser for The Japan Federation of Medical Devices Associations (2021-)
  • Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021-)

Practice Group

  • Healthcare Practice Group
  • M&A Practice Group

Bar Admissions

admitted in Japan, 2009; Illinois, 2016
Daini Tokyo Bar Association